Intracardiac Echocardiography Devices Market size to grow by USD 11.5 billion from 2022 to 2030; Increasing number of heart-related medical conditions and treatments to boost the market growth - Facts & Factor

28 Jun 2023
NEW YORK, June 28, 2023 /PRNewswire/ -- As per Facts and Factors study,
the global intracardiac echocardiography devices market size was worth around USD 6.25 billion in 2021 and is predicted to grow to around USD 11.5 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.76% between 2022 and 2030.
Report Link with All Related Graphs & Charts
: https://www.fnfresearch.com/intracardiac-echocardiography-devices-market
Intracardiac Echocardiography Devices Market: Overview
Intracardiac echocardiography (ICE) is a modern and unique medical technique used for imaging and providing high-definition, superior-resolution visualization of cardiac units and structures along with continuous and accurate monitoring of the exact location of the catheter in the heart. The images and information provided are in real-time and hence extremely helpful in the healthcare industry during various medical procedures related to the heart. ICE is also for early detection of any procedural complication that may arise during operations including thrombus formation or pericardial effusion. Thrombus formation occurs when a blood clot is formed within arteries or veins and it can emerge in the heart.
Pericardial effusion is a medical condition in which extra fluid gets collected between the pericardium and the heart. This can lead to increased pressure on the heart restricting the normal movement of blood. Infection can arise if pericardial effusion leads to infection. With the growing use of intracardiac echocardiography, the demand for transesophageal echocardiography has reduced considerably because ICE provides better outputs. ICE is a complete intraprocedural guiding and imaging tool with wide applications for diagnostic purposes.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.fnfresearch.com/sample/intracardiac-echocardiography-devices-market
Key Insights:
As per the analysis shared by our research analyst, the global intracardiac echocardiography devices market is estimated to grow annually at a CAGR of around 5.76% over the forecast period (2022-2030)
In terms of revenue, the global intracardiac echocardiography devices market size was valued at around USD 6.25 billion in 2021 and is projected to reach USD 11.5 billion, by 2030.
The market is projected to grow at a significant rate due to the increasing number of heart-related medical conditions and treatment
Based on application segmentation, septal defects were predicted to show maximum market share in the year 2021
Based on end-user segmentation, hospitals were the leading users in 2021
On the basis of region, North America was the leading revenue generator in 2021
Facts and Factors published the latest report titled
"Intracardiac Echocardiography Devices Market Size, Share, Growth Analysis Report By End-User (Catheterization Laboratories, Hospitals, and Others), By Application (Left Atrial Appendage Closure, Electrophysiology Procedures, Septal Defects, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" into their research database.
Industry Dynamics:
Global Intracardiac Echocardiography Devices Market: Growth Drivers
Increasing number of heart-related medical conditions and treatments to propel market growth.
The global intracardiac echocardiography devices market is projected to grow owing to the increasing number of patients suffering from heart-related conditions and their subsequent treatment. ICE is an effective tool that can be used during operations to monitor the various aspects of functions of the heart as opposed to other imaging techniques which generally require the images to be taken before the operations. Most traditional tools like transoesophageal echocardiography (TEE) are used to prepare for and act as guiding tools during interventional treatment.
However, ICE is an intraprocedural guiding tool which means that it provides information in real-time and hence is more useful during critical operations. There are various other benefits associated with the use of ICE devices. For instance, it provides higher patient tolerance, can also help in reducing fluoroscopy time, and does not require the need for a second operator or general anesthesia. The introduction of ICE in the medical sector has acted as a major advantage in cardiac imaging and currently it has become an integral part of the various electrophysiology and percutaneous interventional procedures.
Directly Purchase a Copy of the Report @ https://www.fnfresearch.com/buynow/su/intracardiac-echocardiography-devices-market
Global Intracardiac Echocardiography Devices Market: Segmentation
The global intracardiac echocardiography devices market is segmented based on end-user, application, and region.
Based on end-user, the global market divisions are catheterization laboratories, hospitals, and others. The global market registered the highest growth in the hospitals segment due to the growing investments in healthcare infrastructure around the globe. Access to medical care has been at the top of the priority list of international and domestic healthcare agencies. The mass efforts undertaken by such bodies have resulted in creating awareness among the population as well as the market players toward the healthcare segment.
For instance, in December 2022, Japan became one of the few countries to adopt Universal Health Coverage (UHC). The country already has one of the best health insurance systems in the world and the main reason driving this growth is the access to required healthcare services for all Japanese citizens. The catheterization laboratories segment registered growth in 19% of the market share due to high product penetration.
Based on application, the global market segments are left atrial appendage closure, electrophysiology procedures, septal defects, and others. In 2021, more than USD 44 million was generated from the septal defects segment and the same growth trend is expected in the future. A ventricular septal defect is related to a medical condition in which there is a hole in the heart. It is a common problem that generally occurs at birth and can be treated during later stages of life with operational procedures. The hole is usually in the wall that acts as a separation for the lower chambers of the ventricles in the heart. It ultimately affects the way blood flows from the lungs and the heart.
Recent Developments:
In July 2021, Royal Philips, a global giant dealing in health technology, announced the success of an operation conducted on the first patient on whom the company's newly launched 3D intracardiac echocardiography catheter was used. The operation conducted was the Left Atrial Appendage Occlusion (LAAO) procedure and was carried out at the Mayo Clinic in Minnesota
In April 2022, the Food and Drugs Administration authority provide clearance to the UltraNav Transseptal Catheter System developed by Franklin Mountain Medical
Get More Insight before [email protected]: https://www.fnfresearch.com/inquiry/intracardiac-echocardiography-devices-market
List of Key Players in Intracardiac Echocardiography Devices Market:
InfraredxTM
Kaixin
NIPRO
Siemens Healthcare AG
Others
Key questions answered in this report:
What are the growth rate forecast and market size for Intracardiac Echocardiography Devices Market?
What are the key driving factors propelling the Intracardiac Echocardiography Devices Market forward?
What are the most important companies in the Intracardiac Echocardiography Devices Market Industry?
What segments does the Intracardiac Echocardiography Devices Market cover?
How can I receive a free copy of the Intracardiac Echocardiography Devices Market sample report and company profiles?
Report Scope:
Free Brochure: https://www.fnfresearch.com/ask-to-analyst/intracardiac-echocardiography-devices-market
Regional Dominance:
North America to lead with the highest market share
The global intracardiac echocardiography devices market is projected to register the highest growth in North America with the United States contributing the highest regional revenue. The growth is projected to be propelled by the growing product adoption across the country's healthcare sector as well as increasing investment by the Canadian government in deploying quality medical care practices. High operational procedures for septal defects were also a leading cause in the past for the regional market to register surging growth. As per a 2016 study, 1 in every 1000 people in the US suffers from congenital heart defects.
However, the highly advanced medical infrastructure of the region has allowed the ratio to reduce significantly due to the prompt response of the medical community in treating the cases. Higher revenue is anticipated to be influenced by the growing number of players producing quality devices with constant research & development coupled with product innovation.
Global Intracardiac Echocardiography Devices Market is segmented as follows:
Intracardiac Echocardiography Devices Market: By End-User Outlook (2023-2030)
Catheterization Laboratories
Hospitals
Others
Intracardiac Echocardiography Devices Market: By Application Outlook (2023-2030)
Left Atrial Appendage Closure
Electrophysiology Procedures
Septal Defects
Others
Intracardiac Echocardiography Devices Market: By Region Outlook (2023-2030)
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Browse Other Related Research Reports from Facts and Factors
Wound Care Market
: According to the report published by Facts & Factors, the global wound care market size in terms of market volume was valued at USD 20.6 billion in 2022 and is predicted to surpass USD 30 billion by the end of 2030. The market is expected to grow by a CAGR of 5.6% during the forecast period of 2023-2030.
Cochlear Implant Market
: According to the report published by Facts and Factors, the global cochlear implants market size was worth around USD 1.45 billion in 2022 and is predicted to grow to around USD 2.6 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.8% between 2023 and 2030.
Healthcare Augmented and Virtual Reality Market
: According to the report published by Facts and Factors, the global healthcare augmented and virtual reality market size was worth around USD 2.31 billion in 2022 and is predicted to grow to around USD 19.61 billion by 2030 with a compound annual growth rate (CAGR) of roughly 26.9% between 2023 and 2030.
Orthopedic Prosthetic Market
: According to the report published by Facts & Factors, the global orthopedic prosthetic market size was worth around USD 2.3 billion in 2022 and is predicted to grow to around USD 3.4 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.31% between 2023 and 2030.
Active Wound Care Market
: According to the report published by Facts and Factors, the global active wound care market size was worth around USD 9.35 billion in 2022 and is predicted to grow to around USD 14.2 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.61% between 2023 and 2030.
Browse through Facts and Factors's coverage of the
Global Healthcare Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Facts and Factors is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us
.
Contact Us:
Facts and Factors
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158
Email: [email protected]
Website: https://www.fnfresearch.com/
Logo - https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg
SOURCE FnF Research
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.